210
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prediction of preeclampsia based on maternal serum endoglin level in women with pregestational diabetes mellitus

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon &
Pages 173-180 | Received 10 Jan 2022, Accepted 17 Apr 2022, Published online: 27 Apr 2022

References

  • IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria.
  • National Guideline Alliance (UK). Hypertension in pregnancy: diagnosis and management. London: National Institute for Health and Care Excellence (UK); 2019 Jun. (NICE Guideline, No. 133.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK546004/.
  • Cosentino F, Grant PJ, Aboyans V, et al. ESC Scientific Document Group, 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2020 Jan 7;41(2):255–323.
  • Meis PJ, Goldenberg RL, Mercer BM, et al. Maternal-fetal medicine units network of the national institute of child health and human development the preterm prediction study: risk factors for indicated preterm births. Am J Obstet Gynecol. 1998;178:562–567.
  • Pérez-Roque L, Núñez-Gómez E, Rodríguez-Barbero A, et al. Pregnancy-induced high plasma levels of soluble endoglin in mice lead to preeclampsia symptoms and placental abnormalities. Int J Mol Sci. 2020;22(1):165. Published 2020 Dec 26.
  • Dickens LT, Thomas CC. Updates in gestational diabetes prevalence, treatment, and health policy. CurrentDiabetesReports. 2019 May;19(6):33.
  • Umapathy A, Chamley LW, James JL. Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies. Angiogenesis. 2020 May;23(2):105–117.
  • Helmo FR, Lopes AMM, Carneiro ACDM, et al. Angiogenic and antiangiogenic factors in preeclampsia. PatholResPract. 2018;214(1):7–14.
  • Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, et al. Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:366–381. Epub 2021 Jan 26. PMID: 33529972.
  • Aggarwal PK, Chandel N, Jain V, et al. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. J HumHypertens. 2012;26(4):236–241.
  • Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [published correction appears in N Engl J Med. 2006 Oct 26;355(17):1840]. N Engl J Med. 2006;355(10):992–1005.
  • Powers RW, Jeyabalan A, Clifton RG, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high-risk pregnancies. PLoS One. 2010;5(10):e13263.
  • Brown MA, Magee LA, Kenny LC, et al., International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018 Jul;72(1):24–43.
  • Smirnov IV, Gryazeva IV, Vasileva MY, et al. New highly sensitive sandwich ELISA system for soluble endoglin quantification in different biological fluids. Scand J Clin Lab Invest. 2018 Oct;78(6):515–523. Epub 2018 Oct 1.
  • Anık A, Çelik E, Ö Ç, et al. The relation of serum endocan and soluble endoglin levels with metabolic control in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2020 Jul;23. j/jpem.ahead-of-print/jpem-2020-0146/jpem-2020-0146.xml. DOI:10.1515/jpem-2020-0146.
  • Doghish AS, Bassyouni AA, Mahfouz MH, et al. Plasma endoglin in Type2 diabetic patients with nephropathy. Diabetes Metab Syndr. 2019 Jan-Feb;13(1):764–768. Epub 2018 Dec 5. PMID: 30641803.
  • Cawyer CR, Horvat D, Leonard D, et al. Hyperglycemia impairs cytotrophoblast function via stress signaling. Am J Obstet Gynecol. 2014;211(5):541.e1‐541.e5418.
  • Cawyer C, Afroze SH, Drever N, et al. Attenuation of hyperglycemia-induced apoptotic signaling and anti-angiogenic milieu in cultured cytotrophoblast cells. HypertensPregnancy. 2016;35(2):159–169.
  • Han CS, Herrin MA, Pitruzzello MC, et al. Glucose and metformin modulate human first trimester trophoblast function: a model and potential therapy for diabetes-associated uteroplacental insufficiency. Am J Reprod Immunol. 2015;73(4):362–371.
  • Holmes VA, Young IS, Patterson CC, et al. The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 diabetes. Diabetes Care. 2013;36(11):3671–3677.
  • Yu Y, Jenkins AJ, Nankervis AJ, et al. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia. 2009;52(1):160–168.
  • Sela S, Itin A, Natanson-Yaron S, et al. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. CircRes. 2008;102(12):1566–1574.
  • Moore Simas TA, Crawford SL, Bathgate S, et al. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. J Matern Fetal Neonatal Med. 2014Jul;27(10):1038–1048. Epub 2013 Oct 29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.